• Kintara Therapeutics Granted Fast Track Designation from FDA for REM-001 for Cutaneous Metastatic Breast Cancer

    1 month ago - By San Diego Biotechnology

    SAN DIEGO, Nov. 28, 2022 /PRNewswire/ - Kintara Therapeutics, Inc. , a biopharmaceutical company focused on the development of new solid tumor cancer therapies, today announced that the United States...
    Read more ...